Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Prostatic Neoplasms 2Anxiety Disorders 2Stomach Neoplasms 1Skin Neoplasms 1Sedation 1Respiratory Aspiration 1Respiration Disorders 1Rectal Neoplasms 1Rare Diseases 1Personal Satisfaction 1Parasomnias 1Pain, Postoperative 1Pain 1Neoplasms 1Lung Neoplasms 1Glioma 1Emergence Delirium 1Diverticulosis, Colonic 1Cough 1Colorectal Neoplasms 1Colonic Neoplasms 1Carcinoma, Squamous Cell 1Carcinoma, Basal Cell 1Breast Neoplasms 1Agnosia 1

Interventions

Propofol 3Dexmedetomidine 3Saline Solution 2remimazolam 1Sufentanil 1Ropivacaine 1Midazolam 1Methylene Blue 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Emergence Delirium × Midazolam × Clear all
NCT05466279 2024-01-25

The Role of Remazolam in Reducing the Incidence of Postoperative Delirium in Elderly Patients

Zhejiang Cancer Hospital

Phase NA Completed
131 enrolled

Emergence Delirium

Data powered by HemOnc (CC BY 4.0) Colophon âš¡